InvestorsHub Logo
Followers 18
Posts 6649
Boards Moderated 0
Alias Born 03/06/2010

Re: cuggegrosse post# 376461

Tuesday, 12/27/2022 8:35:47 AM

Tuesday, December 27, 2022 8:35:47 AM

Post# of 401583
Pre-profitability the company was going to be the initial leader in opioid deterrent technology, which had the potential of a much larger revenue than what we’re doing today. Adderall ER was last decent drug and it was basically a failure to launch and that was almost 3 years ago. Pipeline & R&D has been stalled since then due to pandemic, but shares to CEO were not. $12M drugs continue to have Elite limp along and we can always continue the ANDA sell off strategy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News